• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    AREX Capital Announces Director Appointment to Enhabit Board

    7/29/24 9:00:00 AM ET
    $EHAB
    Medical/Nursing Services
    Health Care
    Get the next $EHAB alert in real time by email

    Leading Proxy Advisors and Stockholders Supported Mandate for Change

    AREX Capital Management, LP (together with its affiliates, "AREX"), the beneficial owner of approximately 4.9% of the outstanding common shares of Enhabit, Inc. (NYSE:EHAB) ("Enhabit" or the "Company"), today commented on the outcome of Enhabit's 2024 Annual Meeting of Stockholders (the "Annual Meeting"), in which stockholders elected Mark W. Ohlendorf to the Company's board of directors (the "Board").

    AREX Managing Partner, Andrew Rechtschaffen, and Partner, James T. Corcoran, commented:

    "We are pleased that stockholders have elected Mark W. Ohlendorf to the Board. Mark will add critically needed financial expertise and oversight, and we look forward to improved financial reporting, guidance accuracy, and investor communications.

    Our campaign engaged in a detailed, facts-based discussion highlighting Enhabit's poor financial and operational performance during its first two years as a public company and proposed specific strategies for achieving significantly better results in the future. It is essential that Enhabit immediately abandon the culture of blaming external factors for its results, and that the Board begins to firmly enforce a culture of accountability and the pursuit of excellence.

    One thing is clear—the Board should not interpret this outcome as a mandate for the status quo or as stockholder approval of its efforts to date. Beyond Mr. Ohlendorf, three of our other nominees each received more than 40% of votes cast, and stockholders withheld significant support from three of the continuing directors. Moreover, both leading proxy advisory firms, Institutional Shareholder Services Inc. and Glass, Lewis, & Co., agreed with our view that Enhabit would benefit from additional home health and hospice expertise and recommended that three directors be replaced.

    Stockholders have clearly put the Board on notice that the era of underperforming expectations and making excuses must end, and that a new era of achieving meaningfully improved results commensurate with the Company's immense potential must begin. It is imperative that the Board do everything in its power to help correct Enhabit's severe undervaluation and drive better outcomes for stockholders.

    We look forward to remaining highly engaged with the Company."

    About AREX

    AREX Capital Management, LP is a value-oriented investment firm based in New York City. AREX takes a long-term, opportunistic approach to investing and focuses primarily on publicly traded companies with significant, unrealized potential.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240729967894/en/

    Get the next $EHAB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $EHAB

    DatePrice TargetRatingAnalyst
    1/22/2026$14.00Perform → Outperform
    Oppenheimer
    1/13/2026$12.00Hold → Buy
    TD Cowen
    1/8/2026$12.00Neutral → Buy
    UBS
    1/7/2026$10.50Hold
    Truist
    12/9/2024$8.25 → $9.50Hold → Buy
    Jefferies
    5/14/2024$8.50Underperform → Market Perform
    Leerink Partners
    5/9/2024$14.00 → $8.75Buy → Hold
    Jefferies
    3/7/2024$9.50Sell → Neutral
    UBS
    More analyst ratings

    $EHAB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Enhabit Reports Fourth Quarter 2025 Financial Results

    Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice care provider, today reported its results of operations for the fourth quarter ended Dec. 31, 2025. "Our fourth quarter 2025 results capped a pivotal year for Enhabit, delivering an emerging growth story with year over year increases in patient census, revenue and Adjusted EBITDA," said Barb Jacobsmeyer, CEO and president of Enhabit. "The consistent execution of our strategy throughout the year materially improved free cash flow, enabling us to further strengthen our balance sheet, positioning us well to accelerate growth and investment in 2026." QUARTERLY PERFORMANCE - CONSOLIDATED Net service revenue of $270.4 million

    3/4/26 4:10:00 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Enhabit to be Acquired by Kinderhook Industries

    Enhabit, Inc. Stockholders to Receive $13.80 per Share in Cash Enhabit, Inc. (NYSE:EHAB), a leading national home health and hospice provider, today announced it has entered into a definitive agreement to be acquired by Kinderhook Industries, LLC ("Kinderhook"), a middle market private equity firm, in an all-cash transaction for a total enterprise value of approximately $1.1 billion. Under the terms of the agreement, Enhabit stockholders will receive $13.80 per share in cash, which represents a premium of approximately 24.4% to the Company's closing stock price on February 20, 2026, the last full trading day prior to the announcement of the transaction, and a 33.8% premium to the Compan

    2/23/26 8:00:00 AM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Enhabit Home Health & Hospice Announces Date of 2025 Fourth Quarter Earnings Call

    Enhabit, Inc. (NYSE:EHAB), a leading national home health and hospice provider, today announced it will report its financial results for the fourth quarter and fiscal year ended Dec. 31, 2025, on March 4, 2026, and host a webcast and conference call on March 5, 2026. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time. March 5, 2026 9 a.m. EST Toll-free: 888-660-6150 International: 929-203-0843 Conference ID: 5248158 Webcast link: https://events.q4inc.com/attendee/846254002 A link to the webcast of the conference call and online replay can be found on Enhabit's investor website. About Enhabit

    2/12/26 4:15:00 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    $EHAB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    General Counsel and Secretary Black Dylan C covered exercise/tax liability with 11,054 shares and was granted 19,228 shares, increasing direct ownership by 11% to 84,499 units (SEC Form 4)

    4 - Enhabit, Inc. (0001803737) (Issuer)

    3/3/26 5:49:14 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Chief Human Resources Officer Marion Tanya Renee covered exercise/tax liability with 8,944 shares and was granted 14,425 shares, increasing direct ownership by 7% to 89,291 units (SEC Form 4)

    4 - Enhabit, Inc. (0001803737) (Issuer)

    3/3/26 5:48:33 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    EVP of Home Health Operations Jolley Julie Diane covered exercise/tax liability with 12,561 shares and was granted 21,430 shares, increasing direct ownership by 7% to 127,244 units (SEC Form 4)

    4 - Enhabit, Inc. (0001803737) (Issuer)

    3/3/26 5:47:48 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    $EHAB
    SEC Filings

    View All

    Enhabit Inc. filed SEC Form 8-K: Leadership Update

    8-K - Enhabit, Inc. (0001803737) (Filer)

    2/27/26 4:27:47 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    SEC Form DEFA14A filed by Enhabit Inc.

    DEFA14A - Enhabit, Inc. (0001803737) (Filer)

    2/26/26 4:06:39 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    SEC Form DEFA14A filed by Enhabit Inc.

    DEFA14A - Enhabit, Inc. (0001803737) (Filer)

    2/23/26 4:59:59 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    $EHAB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Solomon Ryan bought $76,400 worth of shares (10,000 units at $7.64), increasing direct ownership by 5% to 193,468 units (SEC Form 4)

    4 - Enhabit, Inc. (0001803737) (Issuer)

    8/11/25 6:30:04 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Director Bolton Jeffrey bought $34,760 worth of shares (4,000 units at $8.69), increasing direct ownership by 4% to 98,144 units (SEC Form 4)

    4 - Enhabit, Inc. (0001803737) (Issuer)

    12/12/24 5:01:19 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Director Mcguigan Stuart M bought $132,150 worth of shares (15,000 units at $8.81), increasing direct ownership by 47% to 46,810 units (SEC Form 4)

    4 - Enhabit, Inc. (0001803737) (Issuer)

    12/11/24 5:56:33 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    $EHAB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Enhabit Inc. upgraded by Oppenheimer with a new price target

    Oppenheimer upgraded Enhabit Inc. from Perform to Outperform and set a new price target of $14.00

    1/22/26 8:46:17 AM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Enhabit Inc. upgraded by TD Cowen with a new price target

    TD Cowen upgraded Enhabit Inc. from Hold to Buy and set a new price target of $12.00

    1/13/26 8:41:29 AM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Enhabit Inc. upgraded by UBS with a new price target

    UBS upgraded Enhabit Inc. from Neutral to Buy and set a new price target of $12.00

    1/8/26 8:09:53 AM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    $EHAB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Enhabit Inc.

    SC 13G - Enhabit, Inc. (0001803737) (Subject)

    11/14/24 9:12:39 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by Enhabit Inc.

    SC 13G/A - Enhabit, Inc. (0001803737) (Subject)

    10/4/24 1:56:05 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G/A filed by Enhabit Inc. (Amendment)

    SC 13G/A - Enhabit, Inc. (0001803737) (Subject)

    2/13/24 5:04:31 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    $EHAB
    Leadership Updates

    Live Leadership Updates

    View All

    Delaware Court of Chancery Awards Damages and Other Relief to Encompass Health and Enhabit for Misconduct by April Anthony, Other Former Officers, and Private Equity Firms Vistria Group and Nautic Partners

    On Monday, Encompass Health and Enhabit won their lawsuit in the Delaware Court of Chancery related to breaches of fiduciary duty by April Anthony, Luke James, and Chris Walker while they served as the senior officers at Encompass Health's former home health and hospice division, which is now Enhabit. The Court awarded judgment against private equity firms Vistria Group and Nautic Partners and the home health and hospice business now known as VitalCaring Group for aiding and abetting "the egregious breaches of the duty of loyalty" by Anthony, James, and Walker. The case was the subject of a 7-day trial in December 2023. After considering "the damning record presented at trial," the Court

    12/4/24 8:30:00 AM ET
    $EHAB
    $EHC
    Medical/Nursing Services
    Health Care
    Hospital/Nursing Management

    Enhabit Home Health & Hospice Appoints Ryan Solomon as Chief Financial Officer

    Seasoned Industry Executive Brings Significant Financial Operations Expertise and Track Record of Driving Growth and Value Creation Enhabit, Inc. (NYSE:EHAB), ("Enhabit"), a leading home health and hospice provider, today announced the appointment of Ryan Solomon as its next chief financial officer (CFO), effective Dec. 9, 2024. Mr. Solomon's appointment follows the previously announced transition of Crissy Carlisle, CFO. Mr. Solomon brings to Enhabit over 20 years of corporate strategy and finance experience, including eight years as CFO in the home health and hospice space and other industries. Mr. Solomon previously served as CFO of AccentCare, where he was responsible for financial pl

    11/7/24 7:30:00 AM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    American Water Appoints New Independent Member to the Board of Directors

    American Water Works Company, Inc. (NYSE:AWK) announced today that Stuart M. McGuigan has been appointed as an independent member of the company's board of directors, effective Oct. 29, 2024. "American Water is pleased to have Stuart join our board of directors," said Karl Kurz, Board Chair of American Water. "Stuart has more than 38 years of extensive experience in information technology and management including serving as the Chief Information Officer for national and global public companies, as well as a government agency. He will further strengthen our board, and we look forward to working with him." "We are honored to have Stuart become part of American Water's board," said M. Susan

    10/30/24 4:46:00 PM ET
    $AWK
    $EHAB
    Water Supply
    Utilities
    Medical/Nursing Services
    Health Care

    $EHAB
    Financials

    Live finance-specific insights

    View All

    Enhabit Reports Fourth Quarter 2025 Financial Results

    Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice care provider, today reported its results of operations for the fourth quarter ended Dec. 31, 2025. "Our fourth quarter 2025 results capped a pivotal year for Enhabit, delivering an emerging growth story with year over year increases in patient census, revenue and Adjusted EBITDA," said Barb Jacobsmeyer, CEO and president of Enhabit. "The consistent execution of our strategy throughout the year materially improved free cash flow, enabling us to further strengthen our balance sheet, positioning us well to accelerate growth and investment in 2026." QUARTERLY PERFORMANCE - CONSOLIDATED Net service revenue of $270.4 million

    3/4/26 4:10:00 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Enhabit to be Acquired by Kinderhook Industries

    Enhabit, Inc. Stockholders to Receive $13.80 per Share in Cash Enhabit, Inc. (NYSE:EHAB), a leading national home health and hospice provider, today announced it has entered into a definitive agreement to be acquired by Kinderhook Industries, LLC ("Kinderhook"), a middle market private equity firm, in an all-cash transaction for a total enterprise value of approximately $1.1 billion. Under the terms of the agreement, Enhabit stockholders will receive $13.80 per share in cash, which represents a premium of approximately 24.4% to the Company's closing stock price on February 20, 2026, the last full trading day prior to the announcement of the transaction, and a 33.8% premium to the Compan

    2/23/26 8:00:00 AM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Enhabit Home Health & Hospice Announces Date of 2025 Fourth Quarter Earnings Call

    Enhabit, Inc. (NYSE:EHAB), a leading national home health and hospice provider, today announced it will report its financial results for the fourth quarter and fiscal year ended Dec. 31, 2025, on March 4, 2026, and host a webcast and conference call on March 5, 2026. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time. March 5, 2026 9 a.m. EST Toll-free: 888-660-6150 International: 929-203-0843 Conference ID: 5248158 Webcast link: https://events.q4inc.com/attendee/846254002 A link to the webcast of the conference call and online replay can be found on Enhabit's investor website. About Enhabit

    2/12/26 4:15:00 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care